Reduced peripheral blood dendritic cell and monocyte subsets in MDS patients with systemic inflammatory or dysimmune diseases
暂无分享,去创建一个
A. Vekhoff | E. Solary | M. Mohty | P. Fenaux | L. Adès | E. Durot | N. Vey | J. Rossignol | N. Dulphy | S. Dimicoli-Salazar | Sophie Park | A. Mékinian | O. Kosmider | O. Beyne-Rauzy | O. Fain | P. Hirsch | B. Gaugler | M. D’aveni | A. Banos | L. Voillat | J. Vinit | V. Jachiet | L. Terriou | V. Grobost | P. Peterlin | F. Malard | S. Wickenhauser | Lin-Pierre Zhao | L. Willems | M. Gourin | B. de Renzis | L. Pascal | C. Diéval | A. Dellal | L. Ricard | A. Maria | S. Natarajan‐Ame | M. D'Aveni | S. Natarajan‐Amé
[1] P. Nguyen,et al. Myelodysplastic syndromes , 2009, Nature Reviews Disease Primers.
[2] A. Vekhoff,et al. A Phase II Study of the Efficacy and Tolerance of Azacytidine (AZA) in Steroid Dependent/Refractory Systemic Autoimmune and Inflammatory Disorders (SAID) Associated with MDS or CMML (GFM- AZA-SAID -trial) , 2021, Blood.
[3] F. Carrat,et al. Further characterization of clinical and laboratory features in VEXAS syndrome: large‐scale analysis of a multicentre case series of 116 French patients * , 2021, The British journal of dermatology.
[4] E. Clappier,et al. UBA1 Variations in Neutrophilic Dermatosis Skin Lesions of Patients With VEXAS Syndrome. , 2021, JAMA dermatology.
[5] E. Clappier,et al. Genomic landscape of MDS/CMML associated with systemic inflammatory and autoimmune disease , 2021, Leukemia.
[6] T. D. de Gruijl,et al. Reduced frequencies and functional impairment of dendritic cell subsets and non-classical monocytes in myelodysplastic syndromes , 2021, Haematologica.
[7] J. Mullikin,et al. Somatic Mutations in UBA1 and Severe Adult-Onset Autoinflammatory Disease. , 2020, The New England journal of medicine.
[8] A. List,et al. The central role of inflammatory signaling in the pathogenesis of myelodysplastic syndromes. , 2019, Blood.
[9] P. Fenaux,et al. Autoimmune manifestations associated with myelodysplastic syndromes , 2018, Annals of Hematology.
[10] T. D. de Gruijl,et al. Human Bone Marrow-Derived Myeloid Dendritic Cells Show an Immature Transcriptional and Functional Profile Compared to Their Peripheral Blood Counterparts and Separate from Slan+ Non-Classical Monocytes , 2018, Front. Immunol..
[11] A. Enk,et al. Intracapillary immune complexes recruit and activate slan-expressing CD16+ monocytes in human lupus nephritis. , 2018, JCI insight.
[12] H. Bontkes,et al. Transcriptional profiling reveals functional dichotomy between human slan+ non‐classical monocytes and myeloid dendritic cells , 2017, Journal of leukocyte biology.
[13] Renan Valieris,et al. Human dendritic cells (DCs) are derived from distinct circulating precursors that are precommitted to become CD1c+ or CD141+ DCs , 2016, The Journal of experimental medicine.
[14] M. Cazzola,et al. Time-dependent changes in mortality and transformation risk in MDS. , 2016, Blood.
[15] Mario Cazzola,et al. The 2016 revision to the World Health Organization classification of myeloid neoplasms and acute leukemia. , 2016, Blood.
[16] Ø. Bruserud,et al. Expansion of myeloid derived suppressor cells correlates with number of T regulatory cells and disease progression in myelodysplastic syndrome , 2015, Oncoimmunology.
[17] A. Danek,et al. PHAGOCYTES , GRANULOCYTES , AND MYELOPOIESIS slan-de fi ned subsets of CD 16-positive monocytes : impact of granulomatous in fl ammation and M-CSF receptor mutation , 2015 .
[18] Michael Poidinger,et al. Identification of cDC1- and cDC2-committed DC progenitors reveals early lineage priming at the common DC progenitor stage in the bone marrow , 2015, Nature Immunology.
[19] M. Nussenzweig,et al. Circulating precursors of human CD1c+ and CD141+ dendritic cells , 2015, The Journal of experimental medicine.
[20] P. Fenaux,et al. Myelodysplastic Syndromes (MDS) and autoimmune disorders (AD): cause or consequence? , 2013, Best practice & research. Clinical haematology.
[21] Luca Malcovati,et al. Revised international prognostic scoring system for myelodysplastic syndromes. , 2012, Blood.
[22] Peter Winter,et al. SuperSAGE evidence for CD14++CD16+ monocytes as a third monocyte subset. , 2011, Blood.
[23] Wing-Cheong Wong,et al. Gene expression profiling reveals the defining features of the classical, intermediate, and nonclassical human monocyte subsets. , 2011, Blood.
[24] I. Kotsianidis,et al. Th17 and Foxp3(+) T regulatory cell dynamics and distribution in myelodysplastic syndromes. , 2011, Clinical immunology.
[25] S. Pedreiro,et al. Functional characterization of peripheral blood dendritic cells and monocytes in systemic lupus erythematosus , 2012, Rheumatology International.
[26] Silvano Sozzani,et al. Nomenclature of monocytes and dendritic cells in blood. , 2010, Blood.
[27] J. Casanova,et al. Human CD14dim Monocytes Patrol and Sense Nucleic Acids and Viruses via TLR7 and TLR8 Receptors , 2010, Immunity.
[28] P. Grossmann,et al. Blood dendritic cells in systemic lupus erythematosus exhibit altered activation state and chemokine receptor function , 2009, Annals of the rheumatic diseases.
[29] J. Casanova,et al. Human CD 14 dim Monocytes Patrol and Sense Nucleic Acids and Viruses via TLR 7 and TLR 8 Receptors , 2010 .
[30] G. Mufti,et al. IL‐17‐producing CD4+ T cells, pro‐inflammatory cytokines and apoptosis are increased in low risk myelodysplastic syndrome , 2009, British journal of haematology.
[31] D. Margaritis,et al. Kinetics, function and bone marrow trafficking of CD4+CD25+FOXP3+ regulatory T cells in myelodysplastic syndromes (MDS) , 2009, Leukemia.
[32] Lingyun Sun,et al. Systemic lupus erythematosus patients have increased number of circulating plasmacytoid dendritic cells, but decreased myeloid dendritic cells with deficient CD83 expression , 2008, Lupus.
[33] F. Dammacco,et al. Glomerular accumulation of plasmacytoid dendritic cells in active lupus nephritis: role of interleukin-18. , 2008, Arthritis and rheumatism.
[34] L. Gesualdo,et al. Immature myeloid and plasmacytoid dendritic cells infiltrate renal tubulointerstitium in patients with lupus nephritis. , 2008, Molecular immunology.
[35] Eric Vivier,et al. Novel insights into the relationships between dendritic cell subsets in human and mouse revealed by genome-wide expression profiling , 2008, Genome Biology.
[36] G. Mufti,et al. CD4+CD25high Foxp3+ regulatory T cells in myelodysplastic syndrome (MDS). , 2007, Blood.
[37] K. Schäkel,et al. Human 6-sulfo LacNAc-expressing dendritic cells are principal producers of early interleukin-12 and are controlled by erythrocytes. , 2006, Immunity.
[38] K. Migita,et al. Reduced blood BDCA‐2+ (lymphoid) and CD11c+ (myeloid) dendritic cells in systemic lupus erythematosus , 2005, Clinical and experimental immunology.
[39] P. Smolewski,et al. Clinical significance of circulating dendritic cells in patients with systemic lupus erythematosus. , 2004, Mediators of Inflammation.
[40] K. MacDonald,et al. Characterization of human blood dendritic cell subsets. , 2002, Blood.
[41] V. Pascual,et al. Blood dendritic cells and DC-poietins in systemic lupus erythematosus. , 2002, Human immunology.
[42] K. Schäkel,et al. 6-Sulfo LacNAc, a novel carbohydrate modification of PSGL-1, defines an inflammatory type of human dendritic cells. , 2002, Immunity.
[43] J. Smolen,et al. Alterations of dendritic cells in systemic lupus erythematosus: phenotypic and functional deficiencies. , 2001, Arthritis and rheumatism.
[44] S. Miltenyi,et al. BDCA-2, BDCA-3, and BDCA-4: Three Markers for Distinct Subsets of Dendritic Cells in Human Peripheral Blood , 2000, The Journal of Immunology.
[45] K. Schäkel,et al. A novel dendritic cell population in human blood: one‐step immunomagnetic isolation by a specific mAb (M‐DC8) and in vitro priming of cytotoxic T lymphocytes , 1998, European journal of immunology.